Motilal Oswal Alternates Launches $358 Million Commercial Real Estate Fund
Motilal Oswal Alternates is raising up to $358 million for a new commercial real estate fund targeting early-stage Grade A office developments across major…

Motilal Oswal Alternates has launched its first commercial real estate fund, targeting a total raise of approximately $358 million. The fund, registered as a Category II Alternative Investment Fund with the Securities and Exchange Board of India, has an initial target of $179 million with a $179 million greenshoe option. The sponsor, Motilal Oswal Group, has committed $24 million to the vehicle.
The fund will focus on early-stage equity joint ventures for Grade A office developments across major Indian cities, including Bengaluru, Mumbai, Hyderabad, Pune, Chennai, and Capital Region. It aims to invest in 8 to 10 projects, with a planned tenure of eight years. The strategy targets a composite internal rate of return of 21% to 22%.
Management intends to exit investments within 5 to Management intends to exit investments within 5 to 5.5 years post-construction by selling stabilized assets to Real Estate Investment Trusts (REITs) or other institutional buyers. This move addresses a gap in the market where institutional capital has historically favored completed, income-producing assets over early-stage development projects.
This launch marks the firm’s seventh real estate fund, following six previous vehicles that focused primarily on residential properties. The firm currently manages over $3.58 billion in assets across real estate, private equity, and private credit. The fund is expected to reach its first close by the end of the year, with a total fundraising timeline of 12 months.
More stories
- The Week in Games: GTA 6 turns attention into cash
- US data centres emit 25.7m tonnes of CO2, Harvard says
- German founders need 3,942 hours to open small business
- Leaked Deutsche Bank files test Sewing's reform narrative
- UAE employers plan 2.8% pay rises for 2027
- Bessent urges Nvidia to seek outside CEO as scrutiny grows
- Avalyn Pharma names ex-FDA official Robert Meyer to board in 8-K filing
- Onterris says it won C$9m Canadian environmental services deal tied to 2027 build
Latest news
- Social Security raises 2027 benefits 3.6%
- Hull City 2–0 Brighton: When Resilience Beat Reputation
- David Parr House to honor Victorian art-workman with blue plaque
- Iran's attacks hit 25 tankers near Strait of Hormuz
- FCC approves prison cellphone jamming despite 2.5-mile warning
- Russia strikes Ukraine as Odesa faces electricity strain
- Bahrain reports two injuries after Iranian aerial attacks
- Congress tests Black Democrats' growing policy influence

